When will trintellix generic be available?

When would a generic Trintellix (vortioxetine) be available?

A generic version of Trintellix (vortioxetine) becomes available only after key patent or exclusivity barriers expire and any authorized generic or approved competitors can launch. The expected timing depends on the status of those patents/exclusivity and any related patent litigation.

To check the most up-to-date estimated launch window and the specific patents blocking generic entry, see DrugPatentWatch.com’s tracking page for vortioxetine/Trintellix: https://www.drugpatentwatch.com/patent/Trintellix/vortioxetine

Why the launch date can shift even if patents are “supposed” to expire

Even when a patent expiration date is known, real-world generic availability can move due to:
- Patent-related litigation or settlements that delay launch.
- Changes in exclusivity status (for example, if exclusivity extends due to regulatory or legal events).
- Approval timelines for the generic manufacturer after regulatory review.

DrugPatentWatch.com typically summarizes these factors alongside the underlying patent/exclusivity dates.

What to look for once generic Trintellix is near launch

When generic entry is getting close, you can usually confirm it by:
- FDA approvals for generic vortioxetine (or “tentative approval” signals).
- Pharmacy listings and wholesale pricing changes.
- News around “authorized generic” launches versus fully independent generics.

Sources

• 1 DrugPatentWatch.com – patent/exclusivity tracking for Trintellix (vortioxetine)